Back to Search
EDGAR PEREZ, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1982406781Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.
PMID 19671735·Mol Cancer Ther·2009
6-review
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
PMID 18443902·Breast Cancer Res Treat·2009
6-review
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials.
PMID 18533085·Mayo Clin Proc·2008
8-other
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
PMID 18777950·Clin Breast Cancer·2008
6-review
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
PMID 17890211·Ann Oncol·2007
6-review
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
PMID 17606974·J Clin Oncol·2007
3-trial
Is there a gluteus medius tendon injury during reaming through a modified medial trochanteric portal? A cadaver study.
PMID 17921836·J Orthop Trauma·2007
8-other
Safety of aromatase inhibitors in the adjuvant setting.
PMID 17912638·Breast Cancer Res Treat·2007
4-observational
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
PMID 16822845·J Clin Oncol·2006
4-observational
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
PMID 16809727·J Clin Oncol·2006
4-observational
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.
PMID 16118507·Oncology·2005
3-trial
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
PMID 16381626·Clin Breast Cancer·2005
3-trial
Optimizing adjuvant chemotherapy in early-stage breast cancer.
PMID 16506631·Oncology (Williston Park)·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BAYSTATE MEDICAL CENTER 759 CHESTNUT STREET
SPRINGFIELD, MA 01199 - Phone
- (413) 794-0000
Quick Facts
- NPI
- 1982406781
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile